Better Med Spa’s Liraglutide program uses a daily GLP‑1 receptor agonist injection (Saxenda‑equivalent dosing) to slow gastric emptying, enhance satiety signals, and improve insulin response, helping you eat less, feel fuller, and lose clinically meaningful weight over time. The program layers medication with nutrition, movement, and mindset support, plus safety monitoring for GI, gallbladder, thyroid, and mood‑related risks.

Liraglutide is a GLP‑1 receptor agonist that mimics the gut hormone GLP‑1, binding to GLP‑1 receptors in the pancreas, brain, and GI tract. This increases glucose‑dependent insulin secretion, decreases glucagon, slows gastric emptying, and activates satiety centers in the hypothalamus, leading to reduced hunger, smaller portions, and improved post‑meal glucose control. Clinical trials (e.g., SCALE) show that high‑dose liraglutide can produce significant weight loss and improvements in prediabetes, lipids, and blood pressure when combined with a reduced‑calorie diet and increased activity.
Liraglutide is designed to target:
Liraglutide is believed to help with:
Experience the best in aesthetic and wellness care at Better Med Spa. Our personalized treatments are tailored to you, designed to help you look and feel your absolute best with confidence and ease.
We're here to answer your questions and provide the best services for your needs.
Liraglutide is a daily GLP‑1 receptor agonist (marketed as Saxenda for weight loss, Victoza for diabetes), while Semaglutide is a weekly GLP‑1 with generally greater average weight loss in trials. Liraglutide can still be an excellent option for clients who prefer daily dosing, have specific insurance coverage, or need flexibility around titration and side‑effect management.
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, and injection‑site reactions. Serious risks include pancreatitis, gallbladder disease, kidney issues, and possible gastroparesis or bowel obstruction, plus a boxed warning for thyroid C‑cell tumors based on rodent data and a contraindication in patients with personal/family history of medullary thyroid carcinoma or MEN2. Mood changes and suicidal ideation have also been reported, so psychological screening and monitoring are essential.
Generally adults with BMI ≥30, or ≥27 with weight‑related conditions (like prediabetes, hypertension, or dyslipidemia), who have tried lifestyle changes and are ready for a structured medical program. Candidates must be screened for thyroid cancer risk, pancreatitis history, gallbladder and kidney disease, and mental health history before starting.
Many clients lose around 1–2 pounds per week after titration, with trial data showing significant average percentage weight loss over 6–12+ months when combined with diet and activity. Individual results vary; Better Med Spa emphasizes sustainable loss, muscle preservation, and metabolic health over “crash” numbers.
Liraglutide integrates seamlessly with body‑contouring, peptide stacks (Tesamorelin, Sleep & Sculpt), and K‑Beauty facials to combine internal weight loss with visible sculpting and skin refinement. For revenue and retention, it works best inside monthly memberships that bundle GLP‑1 medication, nutrition coaching, movement goals, and periodic aesthetic treatments, supported by automated follow‑ups and progress tracking.